FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...

UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows

CHICAGO, June 1 /PRNewswire/ -- UCB, Inc. and the Crohn's Disease Working Group (CDWG) today announced the four recipients of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) for Gastroenterology (GI) Fellows, who each will receive a one-year research grant for their original clinica...

California Grants SeqWright License to Operate as a Clinical Laboratory

HOUSTON, March 10 /PRNewswire/ -- SeqWright, a world-wide leader in custom genomic and molecular biology services, announced today that it has been granted a California clinical laboratory license. This license enables SeqWright to utilize its DNA sequencing and Single Nucleotide Polymorphism (SN...

Nasdaq Panel Grants Advanced Life Sciences Request for Continued Listing on Nasdaq Stock Market

CHICAGO, Feb. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), today announced that on February 2, 2009 it received a letter from the Nasdaq Listing Qualifications Panel (the "Panel") informing the Company that the Panel has determined to grant the Company's r...

PRC Government Grants High-Tech Status to AOBO Subsidiaries

NEW YORK, Jan. 13 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB ) ("AOBO" or "the Company"), a leading marketer, distributor and manufacturer of pharmaceutical and healthcare products in China, today announced that the PRC government, led by the Ministry of...

FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for ...

New Young Investigator Grants for Probiotics Research Announced

ALEXANDRIA, Va., Nov. 24 /PRNewswire/ -- The Global Probiotics Council (GPC), a committee formed by Groupe DANONE and Yakult Honsha Co., Ltd., announced the availability of two grants for the second annual Young Investigator Grant for Probiotics Research (YIGPRO) today. Each Young Investigator Gra...

InNexus Biotechnology Receives Patent Grants in Europe

- CEO Morhet to Discuss Continued Expansion of DXL(TM) Patent Protection at 7th Annual BIO Investor Forum - BRITISH COLUMBIA, Canada, Oct. 30 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com ), a drug de...

Nasdaq Grants VirtualScopics' Request for Continued Listing

Extension until February 3, 2009 to meet continued listing criteria ROCHESTER, N.Y., Oct. 9 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP ) today announced that the Nasdaq Hearings Panel has granted the Company's request to remain listed on the Nasdaq Capital Market and has a...

Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics

CARLSBAD, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that its majority-owned subsidiary, Ibis Biosciences, Inc. (Ibis), was awarded government grants and contracts from the United States Department of Agriculture (USDA), National Instit...

EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation

AMSTERDAM, September 22 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) following an allogeneic bone marrow transplan...

Cardinal Health Invites Health Care Providers to Apply for $1 Million in Grants to Fund Patient Safety Initiatives

DUBLIN, Ohio, Sept. 17 /PRNewswire-FirstCall/ -- The Cardinal Health Foundation today announced that for the second year, it will award more than $1 million in funding to help U.S. hospitals, health systems and community health clinics improve patient safety and health care quality. Cardinal...

Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program

WALTHAM, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today announced that the Company has received $1.125 million in research grants to support the development of new treatments for Friedreich's ataxia. The grants are comprised of $1 million from the Muscular...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

PALO ALTO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 34 non-executive officers due to additional hiring, primarily in connection with...

FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011

BOTHELL, WA and VANCOUVER, Aug. 22 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: OGXI ) announced today that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive meta...

GlaxoSmithKline To Post Quarterly US Grants Report

PHILADELPHIA, Aug. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that, beginning in February 2009, the company will proactively report educational and charitable grants provided to US health-related organizations. The report will be updated on a quarterly basis and w...

FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay

- Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems - SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the US Food and Drug Administration (FDA) has a...

FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas

SAN MARINO, Calif., July 9 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of all soft tissue sarcomas. This latest approval is the third clinical indicatio...

US FDA Grants Pediatric Exclusivity for UCB's Keppra(R)

- Period of exclusivity until January 2009 in the US - Pediatric indication filed with FDA SMYRNA, Ga., June 6 /PRNewswire/ -- UCB announced today that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra(R) (levetiracetam). The decis...

Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics

WELLESLEY, Mass., June 3 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, has granted Gen-Probe Incorporated (Nasdaq: GPRO ) and its affiliates a non-exclusive license to use Xceed's novel Flow-Thru Chip technology....

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

PALO ALTO, Calif., May 28 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 31 non-executive officers due to additional hiring, primarily in connection with ...

Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.

NEW YORK, May 19 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has entered into...

Lentigen Corporation Receives Four Research Grants From the National Institutes of Health

BALTIMORE, May 15 /PRNewswire/ -- Lentigen Corporation announced today that it has received four National Institutes of Health (NIH) small business innovation research (SBIR) grants to collaborate with leading scientists. Through these grants, Lentigen will apply its proprietary lentiviral vec...

Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures

'Promise Grants' Offer Individuals, Corporations Unique Opportunities to Invest in Significant Collaborative Research Ventures DALLAS, April 21 /PRNewswire/ -- Susan G. Komen for the Cure(R), the world's largest breast cancer organization, today announced the awarding of more than $100...

European Union, State of Brandenburg, Award Grants to Alcat Europe, GmbH

HENNIGSDORF, Germany, March 6 /PRNewswire/ -- Recently the State of Brandenburg, and the EU, awarded two grants, valued at about 850,000 euro, to Alcat Europe, GmbH, covering marketing and employee costs during early years of operation. Alcat Europe, a laboratory company located in the BioTe...

FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma

NIOX MINO(R) Set to Dramatically Improve Airway Inflammatory Disease Management through Personalized Inflammation Control NEW PROVIDENCE, N.J., March 4 /PRNewswire/ -- Aerocrine, Inc. (http://www.aerocrine.com ) today announced that NIOX MINO (http://www.nioxmino.com ), a hand- he...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

PALO ALTO, Calif., Feb. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 19 non-executive officer employees due to additional hiring, primarily in connec...

United States Patent Office Grants CryoCor's Request for Patent Interference

CryoCor Named Senior Party in Interference SAN DIEGO, Feb. 13 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that the United States Patent and Trademark Office (USPTO) has declared...

FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

KENILWORTH, N.J., Jan. 31 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Peg-IFN (peginterferon alfa-2b) supplemental Biologics License Application (sBLA) for review and has granted Priority ...

FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208

New class of ApoA-I/HDL drugs to reverse atherosclerosis enters the clinic TSX Exchange Symbol: RVX CALGARY, Dec. 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it has received approval by the US Food and Drug Administration (...

NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance

MILWAUKEE, Nov. 1 /PRNewswire-FirstCall/ -- Merge Technologies Incorporated, d.b.a. Merge Healthcare (Nasdaq: MRGE ; TSX: MRG), today announced that the Company received a written notification from the NASDAQ Listing Qualifications Panel stating that the panel determined to continue the listi...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

PALO ALTO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 14 non-executive officers due to additional hiring, primarily in connection with...

Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that its lead product candidate, picoplatin, has been granted orphan medicinal product designation for the treatment o...

Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis

-MPM Bio IV NVS Strategic Fund L.P. invests $10 million in Radius- CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Radius Health ("Radius") announced today that it has granted Novartis (NYSE: NVS ) an option to obtain an exclusive worldwide license (except Japan) to develop and commercialize al...

Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology

IRVINE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW ), a world leader in products and technologies to treat advanced cardiovascular disease, today announced its $5 million multi-year grant to The Henry Samueli School of Engineering at the University o...

NIH grants $750,000 to develop device to determine temperature of neonate's brain

NORFOLK, Va. -- A neonatologist at Childrens Hospital of The Kings Daughters (CHKD) is leading the clinical trials of a $750,000 study funded Friday, Aug. 31, to develop a device to measure the precise temperature of a newborns brain. The National Institutes of Health (NIH) grant stems from rec...

Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

License Exemplifies Broad Applicability of Anesiva's Needle-Free Technology SOUTH SAN FRANCISCO, Calif., and OXFORD, England, Aug. 30 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) and Particle Therapeutics Limited today announced that they have entered into an agreement granting Parti...

FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia

FRAZER, Pa., Aug. 29 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's investigational therapy, TREANDA(R) (bendamustine HCl), for the ...

Mirus Bio Awarded Grants & Contracts of Over $5 Million

MADISON, Wis., Aug. 23 /PRNewswire/ -- Mirus Bio Corporation today announced that it has been awarded five federal grants and contracts since January of this year totaling $5.4 million. They include: -- Two Phase II SBIR grants totaling $2.4 million to further develop the Company's Dynami...

PTC Therapeutics Receives $2.6 Million in Government Grants

- Funding supports continued focus on rare disorders - SOUTH PLAINFIELD, N.J., June 15 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of two government grants to support clinical development programs in rare disorders. The U.S. Department of Defense Neurofibromatosi...